Wai Hei Tse

Wai Hei Tse

Auto-generated profile, based on publicly available information

Wai Hei Tse

Department of Medical Biophysics, University of Western Ontario, London, ON, N6A 3K7, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Discover Nano
Verified
Journal Article
Open access
PDF file
YCYi Chen
Yi Chen
WTWai Hei Tse
Wai Hei Tse
LCLongyan Chen
Longyan Chen
JZJin Zhang
Jin Zhang
Heteronanostructured zinc oxide nanorod (ZnO NR) array are vertically grown on polydimethylsiloxane (PDMS) through a hydrothermal method followed by an in situ deposition of silver nanoparticles (Ag NPs) through a photoreduction process. The Ag-ZnO heterostructured nanorods on PDMS are measured with an average diameter of 160 nm and an average length of 2 μm. ZnO NRs measured by high-resolution transmission electron microscope (HRTEM) shows highly crystalline with a lattice fringe of 0.255 nm, which corresponds to the (0002) planes in ZnO crystal lattice. The average diameter of the Ag NPs in situ deposited on the ZnO NRs is estimated at 22 ± 2 nm. As compared to the bare ZnO NRs, the heterostructured Ag-ZnO nanorod array shows enhanced ultraviolet (UV) absorption at 440 nm, and significant emission in the visible region (λem = 542 nm). In addition, the antimicrobial efficiency of Ag-ZnO heterostructured nanorod array shows obvious improvement as compared to bare ZnO nanorod array. The cytotoxicity of ZnO nanorod array with and without Ag NPs was studied by using 3 T3 mouse fibroblast cell line. No significant toxic effect is imposed on the cells.

15 March 2019 in Discover Nano
Verified
Journal Article
Open access
PDF file
SYSonglin Yang
Songlin Yang
WTWai Hei Tse
Wai Hei Tse
JZJin Zhang
Jin Zhang
A suitable surface is vital for maintaining or even promoting cells’ function and communication. Recently, studies show that nanostructured coatings could have a potential in improving cell adhesion. However, it hardly minimizes the contamination by using traditional solution-coating technology. Matrix-assisted pulsed laser evaporation (MAPLE) technique is a contamination-free process and demonstrates an efficient process to deposit biopolymer without damaging their backbone on the surface of various substrates. Here, upconversion nanoparticles (NaGdF4: Yb3+, Er3+) with/without immunoglobulin G (IgG) modification were produced by a one-pot synthesis method. The average size of the upconversion nanoparticles (UCNPs) is 50 ± 8 nm. IgG bio-conjugated on the surface of UCNPs can be directly observed by transmission electron microscope (TEM). MAPLE system utilizing a Nd:YAG laser (λ = 532 nm, ν = 10 Hz) is applied to deposit UCNPs with/without IgG modification on the glass bottom of culture dish. In addition, the behaviors of human umbilical vein endothelial cells (HUVECs) cultured on the culture dishes coated with UCNPs with/without IgG have been studied as compared to the control sample, glass coated with gelatin. No toxic effect is imposed on cells. The results of this work indicate that the deposition of UCNPs with/without antibody by the MAPLE technique could enhance the adhesion and proliferation of cells.

1 August 2022 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
WTWai Hei Tse
Wai Hei Tse
SHSean Higgins
Sean Higgins
DPDaywin Patel
Daywin Patel
MXMalcolm Xing
Malcolm Xing
AWAdrian R. West
Adrian R. West
RKRichard Keijzer
Richard Keijzer
Nanoparticles administered into the maternal circulation and across the placenta are a potential clinical therapy to treat congenital diseases. The mechanism by which nanoparticles can safely cross the placenta for targeted drug delivery to the fetus remains poorly understood. We demonstrate that the maternal-fetal transfer of passive immunity through the neonatal Fc Receptor (FcRn) can induce the transplacental transfer of chitosan nanoparticles modifed with IgG antibodies (414 ± 27 nm). The transfer of FITC-tagged IgG-modified chitosan nanoparticles was 2.8 times higher (p = 0.0264) compared to similarly-sized unmodified chitosan nanoparticles (375 ± 17 nm). Co-administration of free IgG competitively diminished the transplacental transfer of IgG-modified nanoparticles, yet unmodified nanoparticles remained unaffected. Colocalization of the FcRn and the IgG-modified chitosan nanoparticles were observed with confocal microscopy. Barrier function before and after nanoparticle administration remained intact as determined by TEER (75–79 Ω cm2) and immmunofluorescence of ZO-1 tight junction proteins. The results provide insight into the clinical applications of nanoparticles for prenatal therapies using the mechanism of the maternal-fetal transfer of passive immunity.